Titration on Mounjaro - the 2.5mg to 15mg journey

Tirzepatide (Mounjaro) comes in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg. The manufacturer's standard titration schedule moves you up one step every four weeks. Most patients follow close to that schedule. Some stop earlier because they have reached their goal. Some hold at a lower dose because they are responding well. This article walks through what happens at each step.

Week 1-4: Mounjaro 2.5mg

This is the tolerance dose. Not therapeutic. Its job is to let your gastrointestinal system adapt to GLP-1 signalling without the full metabolic load.

What to expect: mild appetite reduction. Possibly some nausea in the first 24 hours after injection. Mild constipation beginning by week 2-3. Weight loss of 1-3kg by the end of week 4 (some patients lose none, which is fine at this dose).

If you tolerate 2.5mg poorly (significant nausea, vomiting, unable to eat properly), we slow the next step and may stay at 2.5mg for another 2-4 weeks.

Week 5-8: Mounjaro 5mg

The first therapeutic dose. Appetite effects become clearly noticeable. Food noise quieter, portions naturally smaller, sweet foods less appealing.

What to expect: weight loss of 3-5kg by end of week 8 on top of week-4 weight. Most common side effect window. Nausea typically peaks in this block and then settles.

Patient check-in: many patients are already satisfied with the effect at 5mg and want to hold. We discuss whether to escalate or plateau here based on your goal and how you are tolerating.

Week 9-12: Mounjaro 7.5mg

Step up if you want more effect. Weight loss at 7.5mg continues at roughly 1kg per month for most patients.

What to expect: stronger appetite effect; patients sometimes report they forget to eat entirely and need to set meal-time reminders. Some increase in fatigue in the first week after the escalation.

This is a common "hold" point. Patients who are losing weight steadily and tolerating the medication well often decide 7.5mg is enough.

Week 13-16: Mounjaro 10mg

For patients who have a larger weight-loss goal or whose weight loss has plateaued at 7.5mg.

What to expect: further weight loss, often at a slower rate than at lower doses because the body is adapting. Patients describe the appetite effect as "loud" at this dose.

If you are on 10mg and still experiencing side effects, we usually hold. We will not push the dose up just to reach a number.

Week 17-20: Mounjaro 12.5mg and 15mg

Reserved for patients with substantial weight-loss goals (more than 20 percent of starting weight needed) or those whose response has plateaued at lower doses.

12.5mg and 15mg are not required for most patients. The trial data show increasing weight loss up to 15mg, but the additional effect beyond 10mg is real but modest, and side effects are more pronounced.

We escalate to 12.5mg only if:

Weight loss has clearly plateaued at 10mg for 6-8 weeks AND

You have more than 5-10 percent of starting weight still to lose AND

You have tolerated 10mg well.

We escalate to 15mg similarly from 12.5mg.

Where people actually stop

Across our cohort and consistent with wider UK data:

~15 percent of patients reach their goal at 5mg.

~30 percent at 7.5mg.

~35 percent at 10mg.

~15 percent at 12.5mg.

~5 percent at 15mg.

The "right" dose is the lowest dose that produces the response you want. There is no medal for reaching maximum dose.

Why we hold a dose rather than escalate

We will hold at the current dose (rather than step up) in any of these situations:

Side effects still significant and not yet settled.

Weight loss still progressing at current dose.

You have reached your goal and want to transition to maintenance.

Your food intake is dropping below 1500 kcal per day and you are at risk of nutritional deficiency.

Your body composition shows more than 25 percent lean-mass loss (too much muscle lost relative to fat).

Holding is not a failure. For many patients it is the right final dose.

What to do the day of your injection

Same day each week, same approximate time. Most patients pick Sunday evening.

Inject into the abdomen, thigh, or upper arm. Rotate sites each week.

Avoid heavy, fatty meals for 3-4 hours before injection if you have been prone to nausea.

Stay well hydrated that day and the following day.

Plan a relatively light day on the 24 hours following injection, especially for the first few weeks. The side-effect window is tightly linked to the time of injection.

When your dose is ready to change

Every four weeks (typically the week before your next pen is due), we check in with you and make the decision together.

Questions we ask:

Is your weight moving at a rate you are happy with?

Are side effects manageable?

How is your food intake? Are you getting enough protein?

How is your sleep and energy?

Have you started any new exercise?

Based on the answers we hold, step up, or (rarely, but legitimate) step down.

The honest bottom line

Mounjaro titration is not a race. Your target dose is whatever lowest dose gives you the weight loss and tolerability you need. Most patients settle between 5mg and 10mg. Your monthly check-in with us is where we make those calls together.

Ready to start?

If this article has made you think medication might help, the next step is a short consultation with one of our weight-management doctors.

Begin your consultation at this link. Online in 30 minutes, or in person at Westfield London.